The Novel VEGF Receptor/MET–Targeted Kinase Inhibitor TAS-115 Has Marked In Vivo Antitumor Properties and a Favorable Tolerability Profile
暂无分享，去创建一个
Masanori Kato | Kimihiro Ito | K. Nishio | S. Ito | Y. Aoyagi | T. Takenaka | Y. Suda | K. Miyadera | Takamasa Suzuki | H. Ochiiwa | A. Hashimoto | K. Yonekura | H. Fujita | Y. Fujioka | H. Kazuno | Jinhong Huang | T. Suefuji | Kosuke Egami